{"title":"罗莎琳德·富兰克林协会自豪地宣布2022年体外应用毒理学奖获得者","authors":"Judy Strickland","doi":"10.1089/aivt.2023.29034.rfs2022","DOIUrl":null,"url":null,"abstract":"Applied In Vitro ToxicologyVol. 9, No. 3 AnnouncementFree AccessRosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro ToxicologyJudy StricklandJudy StricklandInotiv, Inc. Morrisville, NC, USASearch for more papers by this authorPublished Online:19 Sep 2023https://doi.org/10.1089/aivt.2023.29034.rfs2022AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The Rosalind Franklin Society (RFS), in partnership with Mary Ann Liebert, Inc., publishers, enthusiastically congratulate our distinguished recipient of the 2022 annualRFS Award in Sciencefor this journal, which recognizes the outstanding research and published work of women and underrepresented minority scientists, physicians, and engineers.Judy Strickland, et al., “Application of Defined Approaches to Assess Skin Sensitization Potency of Isothiazolinone Compounds,” Applied In Vitro Toxicology 8, no. 4 (December 2022): 117–128, http://doi.org/10.1089/aivt.2022.0014.AbstractIsothiazolinones are widely used as antimicrobial preservatives in cosmetics and in consumer and industrial products to control bacteria, fungi, and algae. While they are effective biocides, they have the potential to produce skin irritation and sensitization, which poses a human health hazard. In this project, we evaluated non-animal defined approaches for skin sensitization that can provide point-of-departure estimates for use in quantitative risk assessment for isothiazolinones. The skin sensitization potential of six isothiazolinones was evaluated using three internationally harmonized non-animal test methods. Results from these test methods were then applied to two versions of the Shiseido Artificial Neural Network defined approach. Sensitization hazard or potency predictions were compared to those of the in vivo murine local lymph node assay (LLNA). The non-animal methods produced skin sensitization hazard and potency classifications concordant with those of the LLNA. Potency values generated by the defined approaches had less variability than those from the LLNA, and confidence limits from the defined approaches overlapped those of the LLNA for most substances. The application of in silico models to non-animal skin sensitization data is a promising data integration procedure for defined approaches to support hazard and potency classification and quantitative risk assessment.BiosketchDr. Judy Strickland is a principal predictive toxicologist at Inotiv, Inc., with 22 years of experience in evaluating alternative test methods that reduce, refine, or replace animals in regulatory toxicity test methods. Dr. Strickland has both coordinated and evaluated national and international validation studies to assess the performance of non-animal methods for assessing chemical toxicity. Her efforts in evaluating non-animal methods for the assessment of chemical skin sensitizers contributed to the first internationally harmonized guideline for non-animal approaches that can replace animal tests to identify skin sensitizers and classify their potency. This work continues in an effort to broaden the number and type of test methods and approaches accepted, including those can be used to establish safe exposure levels of chemical sensitizers. She serves on the Organization for Economic Cooperation and Development expert group on skin sensitization and the expert group on defined approaches for skin sensitization. Dr. Strickland received a PhD in pharmacology from East Carolina University and is a diplomate of the American Board of Toxicology.FiguresReferencesRelatedDetails Volume 9Issue 3Sep 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Judy Strickland.Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro Toxicology.Applied In Vitro Toxicology.Sep 2023.77-77.http://doi.org/10.1089/aivt.2023.29034.rfs2022Published in Volume: 9 Issue 3: September 19, 2023PDF download","PeriodicalId":37448,"journal":{"name":"Applied In Vitro Toxicology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for <i>Applied In Vitro Toxicology</i>\",\"authors\":\"Judy Strickland\",\"doi\":\"10.1089/aivt.2023.29034.rfs2022\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Applied In Vitro ToxicologyVol. 9, No. 3 AnnouncementFree AccessRosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro ToxicologyJudy StricklandJudy StricklandInotiv, Inc. Morrisville, NC, USASearch for more papers by this authorPublished Online:19 Sep 2023https://doi.org/10.1089/aivt.2023.29034.rfs2022AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The Rosalind Franklin Society (RFS), in partnership with Mary Ann Liebert, Inc., publishers, enthusiastically congratulate our distinguished recipient of the 2022 annualRFS Award in Sciencefor this journal, which recognizes the outstanding research and published work of women and underrepresented minority scientists, physicians, and engineers.Judy Strickland, et al., “Application of Defined Approaches to Assess Skin Sensitization Potency of Isothiazolinone Compounds,” Applied In Vitro Toxicology 8, no. 4 (December 2022): 117–128, http://doi.org/10.1089/aivt.2022.0014.AbstractIsothiazolinones are widely used as antimicrobial preservatives in cosmetics and in consumer and industrial products to control bacteria, fungi, and algae. While they are effective biocides, they have the potential to produce skin irritation and sensitization, which poses a human health hazard. In this project, we evaluated non-animal defined approaches for skin sensitization that can provide point-of-departure estimates for use in quantitative risk assessment for isothiazolinones. The skin sensitization potential of six isothiazolinones was evaluated using three internationally harmonized non-animal test methods. Results from these test methods were then applied to two versions of the Shiseido Artificial Neural Network defined approach. Sensitization hazard or potency predictions were compared to those of the in vivo murine local lymph node assay (LLNA). The non-animal methods produced skin sensitization hazard and potency classifications concordant with those of the LLNA. Potency values generated by the defined approaches had less variability than those from the LLNA, and confidence limits from the defined approaches overlapped those of the LLNA for most substances. The application of in silico models to non-animal skin sensitization data is a promising data integration procedure for defined approaches to support hazard and potency classification and quantitative risk assessment.BiosketchDr. Judy Strickland is a principal predictive toxicologist at Inotiv, Inc., with 22 years of experience in evaluating alternative test methods that reduce, refine, or replace animals in regulatory toxicity test methods. Dr. Strickland has both coordinated and evaluated national and international validation studies to assess the performance of non-animal methods for assessing chemical toxicity. Her efforts in evaluating non-animal methods for the assessment of chemical skin sensitizers contributed to the first internationally harmonized guideline for non-animal approaches that can replace animal tests to identify skin sensitizers and classify their potency. This work continues in an effort to broaden the number and type of test methods and approaches accepted, including those can be used to establish safe exposure levels of chemical sensitizers. She serves on the Organization for Economic Cooperation and Development expert group on skin sensitization and the expert group on defined approaches for skin sensitization. Dr. Strickland received a PhD in pharmacology from East Carolina University and is a diplomate of the American Board of Toxicology.FiguresReferencesRelatedDetails Volume 9Issue 3Sep 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Judy Strickland.Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro Toxicology.Applied In Vitro Toxicology.Sep 2023.77-77.http://doi.org/10.1089/aivt.2023.29034.rfs2022Published in Volume: 9 Issue 3: September 19, 2023PDF download\",\"PeriodicalId\":37448,\"journal\":{\"name\":\"Applied In Vitro Toxicology\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Applied In Vitro Toxicology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/aivt.2023.29034.rfs2022\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Health Professions\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied In Vitro Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/aivt.2023.29034.rfs2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0
摘要
应用体外毒理学卷。9、第3号公告免费访问罗莎琳德富兰克林协会自豪地宣布2022年体外应用毒理学奖获得者judy stricklandMorrisville, NC, usa搜索本文作者的更多论文发表在线:2023年9月19日https://doi.org/10.1089/aivt.2023.29034.rfs2022AboutSectionsPDF/EPUB许可和引文missionsdownload CitationsTrack引文添加到收藏夹返回出版分享分享在facebook上推特上链接在redditemail罗莎琳德·富兰克林协会(RFS)与玛丽·安·利伯特公司合作,出版商,热烈祝贺我们的杰出获奖者获得2022年度科学rfs奖,该奖项旨在表彰女性和未被充分代表的少数民族科学家,医生和工程师的杰出研究和发表工作。Judy Strickland, et al.,“应用确定的方法来评估异噻唑啉酮化合物的皮肤致敏效力”,《体外毒理学应用》8,no。4(2022年12月):117-128,http://doi.org/10.1089/aivt.2022.0014.AbstractIsothiazolinones广泛用作化妆品和消费品及工业产品中的抗菌防腐剂,以控制细菌、真菌和藻类。虽然它们是有效的杀菌剂,但它们有可能产生皮肤刺激和致敏,从而对人体健康构成危害。在这个项目中,我们评估了非动物定义的皮肤致敏方法,这些方法可以提供用于异噻唑啉酮定量风险评估的出发点估计。采用三种国际统一的非动物试验方法评价了6种异噻唑啉酮类药物的皮肤致敏潜力。然后将这些测试方法的结果应用于两个版本的资生堂人工神经网络定义方法。将致敏危险或效力预测与体内小鼠局部淋巴结测定(LLNA)的预测进行比较。非动物方法产生的皮肤致敏危险和效力分类与LLNA一致。与LLNA相比,定义方法产生的效价值具有较小的可变性,并且定义方法的置信限与大多数物质的LLNA的置信限重叠。将计算机模型应用于非动物皮肤致敏数据是一种很有前途的数据整合程序,可以为支持危害和效力分类以及定量风险评估提供明确的方法。Judy Strickland是Inotiv, Inc.的首席预测毒理学家,在评估替代测试方法方面拥有22年的经验,这些方法可以减少,改进或取代动物的监管毒性测试方法。Strickland博士协调和评估了国家和国际验证研究,以评估评估化学毒性的非动物方法的性能。她在评估用于评估化学皮肤致敏剂的非动物方法方面的努力促成了第一个国际统一的非动物方法指南,该指南可以取代动物试验来识别皮肤致敏剂并对其效力进行分类。这项工作将继续努力扩大可接受的测试方法和方法的数量和类型,包括那些可用于确定化学致敏剂安全暴露水平的方法和方法。她是经济合作与发展组织皮肤致敏专家组和皮肤致敏确定方法专家组的成员。Strickland博士获得East Carolina University药理学博士学位,是美国毒理学委员会的外交官。数据参考资料相关信息第9卷第3期2023年9月信息版权所有2023,Mary Ann Liebert, Inc,出版商本文引用:Judy Strickland。罗莎琳德·富兰克林协会自豪地宣布2022年体外应用毒理学奖获得者。应用体外毒理学。九月2023.77-77.http://doi.org/10.1089/aivt.2023.29034.rfs2022Published卷:9期:2023年9月19日pdf下载
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro Toxicology
Applied In Vitro ToxicologyVol. 9, No. 3 AnnouncementFree AccessRosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro ToxicologyJudy StricklandJudy StricklandInotiv, Inc. Morrisville, NC, USASearch for more papers by this authorPublished Online:19 Sep 2023https://doi.org/10.1089/aivt.2023.29034.rfs2022AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail The Rosalind Franklin Society (RFS), in partnership with Mary Ann Liebert, Inc., publishers, enthusiastically congratulate our distinguished recipient of the 2022 annualRFS Award in Sciencefor this journal, which recognizes the outstanding research and published work of women and underrepresented minority scientists, physicians, and engineers.Judy Strickland, et al., “Application of Defined Approaches to Assess Skin Sensitization Potency of Isothiazolinone Compounds,” Applied In Vitro Toxicology 8, no. 4 (December 2022): 117–128, http://doi.org/10.1089/aivt.2022.0014.AbstractIsothiazolinones are widely used as antimicrobial preservatives in cosmetics and in consumer and industrial products to control bacteria, fungi, and algae. While they are effective biocides, they have the potential to produce skin irritation and sensitization, which poses a human health hazard. In this project, we evaluated non-animal defined approaches for skin sensitization that can provide point-of-departure estimates for use in quantitative risk assessment for isothiazolinones. The skin sensitization potential of six isothiazolinones was evaluated using three internationally harmonized non-animal test methods. Results from these test methods were then applied to two versions of the Shiseido Artificial Neural Network defined approach. Sensitization hazard or potency predictions were compared to those of the in vivo murine local lymph node assay (LLNA). The non-animal methods produced skin sensitization hazard and potency classifications concordant with those of the LLNA. Potency values generated by the defined approaches had less variability than those from the LLNA, and confidence limits from the defined approaches overlapped those of the LLNA for most substances. The application of in silico models to non-animal skin sensitization data is a promising data integration procedure for defined approaches to support hazard and potency classification and quantitative risk assessment.BiosketchDr. Judy Strickland is a principal predictive toxicologist at Inotiv, Inc., with 22 years of experience in evaluating alternative test methods that reduce, refine, or replace animals in regulatory toxicity test methods. Dr. Strickland has both coordinated and evaluated national and international validation studies to assess the performance of non-animal methods for assessing chemical toxicity. Her efforts in evaluating non-animal methods for the assessment of chemical skin sensitizers contributed to the first internationally harmonized guideline for non-animal approaches that can replace animal tests to identify skin sensitizers and classify their potency. This work continues in an effort to broaden the number and type of test methods and approaches accepted, including those can be used to establish safe exposure levels of chemical sensitizers. She serves on the Organization for Economic Cooperation and Development expert group on skin sensitization and the expert group on defined approaches for skin sensitization. Dr. Strickland received a PhD in pharmacology from East Carolina University and is a diplomate of the American Board of Toxicology.FiguresReferencesRelatedDetails Volume 9Issue 3Sep 2023 InformationCopyright 2023, Mary Ann Liebert, Inc., publishersTo cite this article:Judy Strickland.Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Applied In Vitro Toxicology.Applied In Vitro Toxicology.Sep 2023.77-77.http://doi.org/10.1089/aivt.2023.29034.rfs2022Published in Volume: 9 Issue 3: September 19, 2023PDF download
期刊介绍:
Applied In Vitro Toxicology is a peer-reviewed journal providing the latest research on the application of alternative in vitro testing methods for predicting adverse effects in the pharmaceutical, chemical, and personal care industries. This Journal aims to address important issues facing the various chemical industries, including regulatory requirements; the reduction, refinement, and replacement of animal testing; new screening methods; evaluation of new cell and tissue models; and the most appropriate methods for assessing safety and satisfying regulatory demands. The Journal also delivers the latest views and opinions of developers of new models, end users of the models, academic laboratories that are inventing new tools, and regulatory agencies in the United States, Europe, Latin America, Australia and Asia. Applied In Vitro Toxicology is the journal that scientists involved with hazard identification and risk assessment will read to understand how new and existing in vitro methods are applied, and the questions for which these models provide answers. Applied In Vitro Toxicology coverage includes: -Applied in vitro toxicology industry standards -New technologies developed for applied in vitro toxicology -Data acquisition, cleaning, distribution, and best practices -Data protection, privacy, and policy -Business interests from research to product -The changing role of in vitro toxicology -Visualization and design principles of applied in vitro toxicology infrastructures -Physical interfaces and robotics -Opportunities around applied in vitro toxicology